<DOC>
	<DOCNO>NCT02648126</DOCNO>
	<brief_summary>The purpose study determine occurrence pure red cell aplasia group participants chronic renal insufficiency resistance criterion epoetin alfa treatment.The investigational product producted Bio-Manguinhos / Fiocruz ( BIO-EPO ) provide Unified Health System .</brief_summary>
	<brief_title>Pure Red Cell Aplasia Patients With Chronic Kidney Disease Use Epoetin Alfa</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Red-Cell Aplasia , Pure</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Use alfa epoetin manufacture BioManguinhos least 8 week moment hyporesponsiveness diagnosis ; Nonuse alfa epoetin another manufacturer least 24 week hyporesponsiveness diagnosis ; Presence criterion pure red cell aplasia disease , absence significant reduction serum level leukocytes platelet . The screened patient least one follow criterion exclude study , may replace another participant research . legal representative , intellectual disability restrain compliance signature inform consent , agreement assign informed consent ; It exclude study moment hyporesponsiveness diagnosis participant : lactation pregnancy , hypersensitivity intolerance previously know alfa epoetin one component , intolerance allergy parenteral iron , acute hemorrhage , kidney transplantation , hemolysis define presence anemia associate high level indirect bilirubin lactate dehydrogenase , percentage reticulocyte &gt; 1.5 % absolute reticulocyte &gt; 75,000 / microliter . deficiency folate / vitamin B12 . pancytopenia . use medication know cause anemia / pure red cell aplasia : Valproic Acid ; Azathioprine ; Chloramphenicol ; Phenytoin ; Isoniazid ; Mycophenolate mofetil . presence follow comorbidities : Diabetes mellitus ; epilepsy ; chronic viral hepatitis ; secondary hyperparathyroidism uncontrolled ; hypertension systolic ; inflammation ( acute chronic ) ; myelofibrosis ; myelodysplasia ; neoplasm thalassemias ; severe disease 24 week hyporesponsiveness diagnosis ; include : stroke , septic shock , thromboembolic event ; acute myocardial infarction lack information damage quality data avoid disease classification case hyporesponsiveness . Immunoglobulin M Immunoglobulin M serology Parvovirus B19 , EpsteinBarr Cytomegalovirus . serology HIV last 12 month . establish immunological disease . dosage protein Creactive titrate . presence antinuclear antibody rheumatoid factor .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>